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Abstract 
The objective of this study was to investigate the hypothesis that the application of dynamic 
compression following transforming growth factor-β3 (TGF-β3) induced differentiation will 
further enhance chondrogenesis of mesenchymal stem cells (MSCs). Porcine MSCs were 
encapsulated in agarose hydrogels and cultured in a chemically defined medium with TGF-β3 
(10 ng/ml). Dynamic compression (1 Hz, 10% strain, 1 hour/day) was initiated at either day 0 
or day 21 and continued until day 42 of culture; with TGF-β3 withdrawn from some groups at 
day 21. Biochemical and mechanical properties of the MSC-seeded constructs were evaluated 
up to day 42. The application of dynamic compression from day 0 inhibited chondrogenesis 
of MSCs. This inhibition of chondrogenesis in response to dynamic compression was not 
observed if MSC-seeded constructs first underwent 21 days of chondrogenic differentiation 
in the presence of TGF-β3. Spatial differences in sGAG accumulation in response to both 
TGF-β3 stimulation and dynamic compression were observed within the constructs. sGAG 
release from the engineered construct into the surrounding culture media was also dependent 
on TGF-β3 stimulation, but was not effected by dynamic compression. Continued 
supplementation with TGF-β3 appeared to be a more potent chondrogenic stimulus than the 
application of 1 hour of daily dynamic compression following cytokine initiated 
differentiation. In the context of cartilage tissue engineering, the results of this study suggest 
that MSC seeded constructs should be first allowed to undergo chondrogenesis in vitro prior 
to implantation in a load bearing environment. 
 
Key Terms: Cartilage, bioreactor, mesenchymal stem cells, functional tissue engineering, 
mechanobiology, dynamic compression. 
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Introduction 
Once damaged articular cartilage has a limited reparative capacity and thus lesions 
often progress to arthritis9. This has motivated the development of cell based therapies for the 
repair of cartilage defects such as autologous chondrocyte implantation6,58. A major limiting 
factor in extending the use of such therapies is obtaining sufficient numbers of viable 
chondrocytes, particularly in elderly and more osteoarthritic patients. An age related loss in 
chondrocyte yield, proliferation and functional capacity has been observed in culture-
expanded chondrocytes5, while chondrocytes isolated from osteoarthritic patients exhibit 
reduced collagen synthesis61. Mesenchymal stem cells (MSCs) are a promising alternative 
cell source for cartilage repair due to both their ease of isolation and expansion, and their 
chondrogenic differentiation capacity14,59,64. Chondrogenic differentiation of MSCs from 
different tissue sources has been shown in the presence of members of the transforming 
growth factor-β (TGF-β) superfamily26,28,29,43,52,55,69,70.  
The same functional demands which put cartilage at risk of injurious damage and 
frequent degenerative changes must be considered in the design and appraisal of any 
therapeutic intervention. In the context of cell based tissue engineering therapies, mechanical 
factors are of particular importance. While chondrogenesis of MSCs has been demonstrated 
in different 3-dimensional scaffolds and hydrogels16,19,36,40,47,68, it has been shown that matrix 
accumulation and the subsequent mechanical properties of MSC laden constructs are lower 
than those of chondrocyte seeded controls19,47. This suggests that further optimisation of the 
cellular environment is required if MSCs are to be used to engineer cartilaginous tissues with 
functional properties similar to those obtainable with chondrocytes. Furthermore, if MSCs are 
to be implanted into the joint as part of a clinical repair strategy, the biomechanical and 
biochemical influences of the joint environment on MSC differentiation and extracellular 
matrix (ECM) synthesis must be determined. 
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Chondrocytes generally respond to physiological levels of dynamic compressive 
loading through enhanced cartilage-specific macromolecule biosynthesis11,17,21,34,46,56,60. The 
differentiation pathway and biosynthetic activity of MSCs is also at least partially regulated 
by the biophysical environment31,38. For example, the mechanical properties of repair tissue 
generated by MSCs transplanted into full-thickness cartilage defects have been shown to 
depend on the location of the injury66, suggesting that the local mechanical environment is 
regulating cellular activity. MSCs have also been cultured in vitro in bioreactors designed to 
mimic certain aspects of in vivo joint loading, most commonly dynamic compression or 
hydrostatic pressure2,24,44. It has been demonstrated that dynamic compressive loading in the 
absence of TGF-β family members can increase chondrogenic gene expression13,24,25,44,57,62 
and stimulate the accretion of cartilage-like extra-cellular matrix (ECM) components35,44,57 
relative to unloaded controls. However, the combined effects of dynamic compression and 
chondrogenic growth factor supplementation on chondrogenesis of MSCs are generally more 
complex13. Dynamic compression in the presence of TGF-β has resulted in increases in both 
chondrogenic gene expression1,24,62 and ECM secretion1,62. Other studies however, indicate 
the contrary, with the combination of dynamic compression and TGF-β resulting in a down-
regulation of chondrogenic gene-expression13 and inferior ECM accumulation35,63 when 
compared to unloaded controls. Previous work in our laboratory investigating the effects of 
long term application of dynamic compression on MSC differentiation in the presence of 
TGF-β3 showed that chondrogenesis was significantly inhibited as evidenced by lower ECM 
deposition and resulting mechanical properties when compared to unloaded controls63. 
It has been shown that the application of dynamic compression to MSC seeded 
constructs in the presence of TGF-β1 applied at early time-points (day 8) results in decreased 
aggrecan gene expression; while loading at later time-points (day 16) leads to increases in 
chondrogenic gene expression50. This suggests that the mechano-sensitivity of MSCs changes 
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depending on the stage of chondrogenesis. In similar bioreactor studies, it has been shown 
that delaying the application of dynamic compression to chondrocyte seeded constructs 
allowing ECM accumulation can enhance subsequent sulphated glycosaminoglycan (sGAG) 
synthesis18 or the mechanical properties of the engineered tissue42. In this study MSCs were 
allowed to undergo differentiation in the presence of TGF-β3 for 21 days prior to initiation of 
delayed dynamic compression. The objective of this study was to test the hypothesis that the 
application of dynamic compression following TGF-β3 induced differentiation would further 
enhance chondrogenesis of MSCs in agarose hydrogel culture. To comprehensively address 
this hypothesis, the study (i) investigated the spatial accumulation of ECM within agarose 
hydrogels; (ii) compared continued TGF-β3 supplementation and dynamic compression as 
potential regulators of post-cytokine initiated MSC chondrogenic differentiation; and (iii) 
assessed the effect of compression and TGF-β3 supplementation on sGAG retention within, 
and release from, MSC seeded agarose hydrogels. 
 
 
Materials and Methods 
Experimental design 
This study comprised of two parts. One, termed “transient TGF-β3” received TGF-β3 
supplementation for the first 21 days of culture, after which it was removed. The second  
termed “continuous TGF-β3” received continuous TGF-β3 supplementation for the 42 day 
culture period. Both parts involved dynamic compression applied after a 21 day period of 
unloaded free-swelling (FS) culture in the presence of TGF-β3. Within each part, half the 
samples taken through 21 days of FS culture were subjected to dynamic compressive culture 
for a further 21 days; termed delayed dynamic compression (DDC). The remainder were kept 
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in FS conditions as a control. An additional group also received dynamic compression culture 
from day 0 through to day 42, termed continuous dynamic compression (CDC). (Details of 
loading magnitude and duration are provided below. The term ‘continuous’ refers to samples 
loaded from day 0). The timeline and conditions are illustrated in Fig. 1. Samples were 
assessed at day 0, day 21 and day 42. 
 
Cell isolation and expansion 
MSCs were isolated from the femora of three 4 month old porcine donors (~50 kg) 
within 3 hours of sacrifice. Porcine MSCs were isolated and expanded according to a 
modified method developed for human MSCs39. MSCs were plated at a seeding density of 
5×103 cells/cm2 in high-glucose Dulbecco’s modified eagles medium (4.5 mg/mL D-Glucose, 
200mM L-Glutamine; hgDMEM) supplemented with 10% foetal bovine serum (FBS) and 
penicillin (100 U/mL)-streptomycin (100 µg/mL) (all GIBCO, Biosciences, Dublin, Ireland) 
and expanded to passage three in a humidified atmosphere at 37°C and 5% CO2. 
 
Agarose hydrogel encapsulation  
MSCs from 3 donors were pooled, suspended in hgDMEM and mixed with 4% 
agarose (Type VII, Sigma-Aldrich, Arklow, Ireland) in phosphate buffered saline (PBS) at a 
ratio of 1:1 at ~40°C, to yield a final gel concentration of 2% and a cell density of 15×106 
cells/mL. The agarose-cell suspension was cast in a stainless steel mould to produce 
cylindrical constructs (Ø 5mm×3mm thickness). Constructs were maintained separately in 12 
well plates with 2.5mL chondrogenic medium (CM) which consisted of hgDMEM 
supplemented with penicillin (100 U/mL)-streptomycin (100 µg/mL), 100 µg/ml sodium 
pyruvate, 40 µg/mL L-proline, 1.5 mg/mL bovine serum albumin, 4.7 µg/mL linoleic acid, 
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1× insulin–transferrin–selenium, 50 µg/mL L-ascorbic acid-2-phosphate (all Sigma-Aldrich, 
Arklow, Ireland). 100 nM dexamethasone (Sigma-Aldrich) and 10 ng/mL TGF-β3 (R&D 
Systems, Abingdon, UK) were added 72 hours after construct fabrication; the day 0 time 
point. Medium was exchanged every 3 or 4 days with 500μL samples taken from 3 wells for 
biochemical analysis. 
 
Dynamic compression application 
Dynamic compressive loading was applied to constructs as outlined in Fig. 1. 
Intermittent dynamic compression (DC) was carried out in an incubator-housed, custom-built 
compressive loading bioreactor, as shown in Fig. 2. Medium used for loading was the same 
as that in which the constructs were maintained (enabling media sampling for sGAG release 
as described below). Axial compression was applied via impermeable platens using an 
electric linear actuator with 0.05 µm resolution (Zaber Technologies Inc., Vancouver, 
Canada). A 1000 g load cell (RDP Electronics Ltd, Wolverhampton, UK) positioned beneath 
the constructs sensed the load applied. The system was controlled and data logged using 
LabVIEW 7 control and data acquisition software (National Instruments Corp., Newbury, 
UK). The dynamic compression protocol consisted of 10% strain amplitude superimposed on 
a 0.01 N/construct preload at a frequency of 1 Hz employed for a period of 1 hour/day, 5 
days/week. 
 
Mechanical testing and analysis of physical parameters 
Constructs were mechanically tested (n=4 or 5) in unconfined compression between 
impermeable platens using a standard materials testing machine with a 5N load cell (Zwick 
Roell Z005, Herefordshire, UK) as previously described7. Briefly, constructs were kept 
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hydrated through immersion in a PBS bath maintained at room temperature. A preload of 
0.01N was applied to ensure that the construct surface was in direct contact with the 
impermeable loading platens. Stress relaxation tests were performed consisting of a ramp 
displacement of 1 µm/s up to 10% strain, which was maintained until equilibrium was 
reached (~30 minutes).  This was followed by a dynamic test where cyclic strain amplitude of 
1% (10%-11% total strain) was applied for 10 cycles at 1Hz. 
 
Biochemical content 
The biochemical content of constructs (n=3 or 4) was assessed at each time point. 
Constructs were cored using a 3mm biopsy punch; the wet mass of each component recorded 
and the construct frozen at -85°C for later analyses. Samples were digested with papain 
(125µg/ml) in 0.1 M sodium acetate, 5 mM L-cysteine HCl, 0.05 M EDTA, pH 6.0 (all 
Sigma–Aldrich) at 60°C under constant rotation for 18hours. DNA content was quantified 
using the Hoechst Bisbenzimide 33258 dye assay as previously described33. The proteoglycan 
content was estimated by quantifying the amount of sulphated glycosaminoglycan (sGAG) in 
constructs using the dimethylmethylene blue dye-binding assay (Blyscan, Biocolor Ltd., 
Carrickfergus, UK), with a shark chondroitin sulphate standard. Total collagen content was 
determined through measurement of the hydroxyproline content30. A hydroxyproline-to-
collagen ratio of 1:7.69 was used27. Samples of cell culture medium taken for analysis at each 
media exchange (n=3) were analysed for sGAG secreted to the media. Total media volume 
was accounted for and the data is presented as the average sGAG released into the media per 
construct. 
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Histology and immunohistochemistry 
Constructs (n=2) were fixed in 4% paraformaldehyde (Sigma-Aldrich), wax 
embedded and sectioned at 5 µm to produce a cross section perpendicular to the disc face. 
Sections were stained for sGAG with 1% alcian blue 8GX (Sigma–Aldrich) in 0.1M HCl, and 
for collagen with picro-sirius red. The deposition of collagen type I and type II was identified 
through immunohistochemistry. Briefly, sections were quenched of peroxidase activity, 
rinsed with PBS before treatment with chondroitinase ABC (Sigma-Aldrich) in a humidified 
environment at 37°C. Slides were rinsed with PBS and non-specific sites were blocked with 
goat serum (Sigma-Aldrich). Sections were then incubated overnight at 4°C with the primary 
antibody; mouse monoclonal collagen type I antibody (1:400; 1.4 mg/mL; Abcam, 
Cambridge, UK) or mouse monoclonal anti-collagen type II (1:100; 1 mg/mL; Abcam). After 
washing in PBS, sections were incubated for 1 hour in the secondary antibody; anti-mouse 
IgG biotin antibody produced in goat (1:400; 1 mg/mL; Sigma-Aldrich). Colour was 
developed using the Vectastain ABC reagent (Vectastain ABC kit, Vector Laboratories, 
Peterborough, UK) followed by exposure to peroxidase DAB substrate kit (Vector 
Laboratories). Negative and positive controls of porcine ligament and cartilage were included 
for each batch. 
 
Statistical analysis 
The study was repeated twice. Unless otherwise stated, results presented are from a 
single replicate which is representative of both in terms of the main study findings. Statistics 
were preformed using MINITAB 15.1 software package (Minitab Ltd., Coventry, UK). 
Groups were analysed for significant differences using a general linear model for analysis of 
variance with factors of group, construct region, growth factor supplementation, dynamic 
compression condition and interactions between these factors examined. Tukey’s test for 
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multiple comparisons was used to compare conditions. Significance was accepted at a level 
of p≤0.05. Numerical and graphical results are presented as mean ± standard deviation. 
 
 
Results 
Differences in construct physical parameters were observed across groups (Table 1). 
Removal of growth factor at day 21 had no effect on construct mass, while loading did have a 
significant effect with FS and DDC in both studies having greater wet weights than constructs 
receiving dynamic compression from day 0 (CDC) at days 21 (p<0.05) and 42 (p<0.00005). 
Loading condition had an effect on thickness with continuous dynamic compression (CDC) 
resulting in inhibition of axial swelling; p<0.00005.  
Staining of construct sections for sGAG and collagen revealed a steady accretion of 
positive staining for all conditions at each time point beyond day 0. At day 21, stronger 
straining for proteoglycan, collagen and specifically collagen type II was observed in the free 
swelling constructs (FS+) when compared to the continuous dynamic compression constructs 
(CDC+) (Fig. 3). This staining was especially prevalent in the pericellular region. At day 42, 
both FS constructs and constructs subjected to delayed dynamic compression (DDC) 
exhibited more intense staining for proteoglycan than continuously loaded (CDC) constructs 
(Fig. 4). Pericellular staining for collagen was evident in all regimes. A significant amount of 
extra-cellular matrix (ECM) staining was evident in FS and DDC constructs which was not 
present in the CDC constructs (Fig. 4). 
Immunohistochemistry indicated a strong presence of collagen type II in both the 
pericellular matrix (PCM) and the ECM of both FS and DDC groups for either TGF-β3 
supplementation condition. Weaker collagen type II staining was evident in the CDC group 
with transient TGF-β3. For FS groups, the core region exhibited more intense staining than 
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the annular region (Fig. 5). A more intense collagen type II staining was evident in constructs 
receiving continued TGF-β3 supplementation when compared to transient supplementation. 
These same constructs stained weakly for collagen type I, while FS and DDC constructs 
receiving transient TGF-β3 supplementation exhibited stronger staining for collagen type I, 
especially in the annular region (Fig. 5). 
 There was a net increase in DNA content indicating cell proliferation at day 42 in 
groups receiving continued TGF-β3 supplementation (Study B; p=0.0059); resulting in 
significantly higher DNA content than groups where TGF-β3 was removed (transient TGF-
β3; p<0.00005; Fig. 6A). sGAG content increased over day 0 values for all experimental 
conditions; p<0.05 (Figs. 6B, 6C & 8B). Removal of TGF-β3, loading condition and 
construct region all had a significant effect on sGAG accumulation; p<0.0005. Regardless of 
TGF-β3 supplementation condition, both FS and DDC constructs had significantly greater 
sGAG content than CDC constructs; p<0.002 (Figs. 6B & 6C). At day 42, sGAG 
accumulation (% wet weight) was significantly greater in constructs continuously 
supplemented with TGF-β3 (Fig. 6B). At the same time point, sGAG/DNA was also greater 
in the cores of these constructs; p=0.0017 (Figs. 7B & 7C).  Following the removal of TGF-
β3 (transient TGF-β3), delayed dynamic compression (DDC-) resulted in a non-significant 
trend towards higher sGAG/DNA in comparison to free-swelling conditions (FS-); p=0.067 
(Fig. 6C). This difference was significant in the construct cores; p<0.05 (Figs. 7B & 7C). 
There was no difference between FS+ and DDC+ groups at day 42. 
 Collagen content increased from day 0 values for all constructs; p<0.0001 (Fig. 6D& 
6E). As with sGAG, loading condition and construct region were seen to have a significant 
effect on collagen content; however TGF-β3 supplementation had no effect on collagen 
accumulation (% wet weight). Collagen accumulation was no different in FS or DDC 
constructs; however both FS- and DDC- constructs contained higher collagen/DNA than the 
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corresponding CDC- constructs; p<0.05 (Fig. 6E, transient TGF-β3). Increases in collagen 
accumulation were greatest in the construct core; p<0.0002 (Figs. 7D & 7E). 
sGAG secreted to the media increased with time in culture with significantly more 
sGAG secreted for all experimental conditions from day 21 - day 42 than day 0 – day 21; 
p<0.0005 (Fig. 8A). Significantly more sGAG was secreted to the media from samples where 
TGF-β3 supplementation ceased at day 21 (transient TGF-β3), than receiving continuous 
supplementation; p<0.00005 (Fig. 8A). Both FS and DDC constructs under both TGF-β3 
conditions secreted significantly more sGAG to the medium than the corresponding 
constructs compressed from day 0 (CDC); p<0.05 (Fig. 8).  
 The compressive equilibrium modulus increased with time for all conditions relative 
to day 0; p<0.05 (Fig. 9A). On day 42, the compressive equilibrium modulus of FS- 
constructs reached a value of 16.17±1.21 kPa; significantly greater than either continuous 
dynamic compression (CDC) group. There were no differences between FS and DDC 
constructs. Increases in the 1Hz dynamic modulus with time were only seen at day 42 for FS 
and DDC constructs; p<0.05 (Fig. 9B). The 1Hz dynamic modulus was not different for both 
FS and DDC constructs, however both were significantly greater than CDC constructs; 
p<0.00005. The 1Hz dynamic modulus was affected by TGF-β3 removal, with continued 
TGF-β3 supplementation resulting in greater dynamic moduli than transient TGF-β3 
supplementation; p=0.031. 
 
Discussion 
The chondrogenic potential of MSCs appears to be regulated by their mechanical 
environment, but this response depends on the stage of chondrogenesis. In the presence of 
TGF-β3, continuous dynamic compression was observed to inhibit chondrogenesis, 
corroborating our previous finding63. By delaying the application of dynamic compression for 
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3 weeks until chondrogenic differentiation had been initiated (as evidenced by histological 
and immunohistochemical staining for proteoglycan and type II collagen), this inhibition of 
chondrogenesis in response to dynamic compression was not observed. There are a number of 
possible explanations for this temporal response to dynamic compression. The phenotype of 
the MSCs on initiation of dynamic compression at day 0 (CDC) and day 21 (DDC) may be 
one such explanation; as a greater level of chondrogenic differentiation may result in a more 
anabolic response to loading similar to that of chondrocytes10,11,17,21,34,45,46,56,60. Mouw et al. 
demonstrated that dynamic compression applied at day 8 resulted in a decrease in aggrecan 
gene expression in MSCs; however when loading was applied at day 16, an increase in 
chondrogenic gene expression was observed50. Related to this, the different levels of matrix 
accumulation at day 0 and day 21 could also be responsible for the differential response to 
dynamic compression in CDC and DDC constructs. The level of PCM and ECM 
accumulation would affect both the local mechanical stimuli developed during loading22, and 
biochemical signalling from the ECM. For example, in a study of dynamically compressed 
single chondrocytes and chondrons (chondrocytes with attached PCM), the presence of a 
PCM regulated the response to mechanical compression67. It has also been demonstrated that 
the stiffness of isolated chondrons seeded into agarose is higher than that of the surrounding 
extracellular agarose environment, leading to stress shielding of the chondrocytes during 
loading37. 
Akin to our previous studies, sGAG and collagen accumulation in MSC laden 
constructs was greatest in the construct core8,63. This may be due to a lower oxygen tension in 
the construct core, as low oxygen tension has been shown to promote chondrogenesis of 
MSCs15,20,53,54. Another explanation for this spatial difference in matrix deposition is that a 
large percentage of the sGAG produced in the annulus is simply secreted into the culture 
medium. Indeed, significant levels of sGAG were measured in the culture media. Similar 
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levels of sGAG release to the media from MSC seeded constructs has been observed in other 
studies4,41. Interestingly, while sGAG accumulation at day 42 was greater in constructs 
continuously maintained in TGF-β3; sGAG secreted to the culture medium was greatest in 
constructs transiently supplemented with TGF-β3. This suggests that continued 
supplementation of TGF-β3 encourages retention of sGAG within the construct. This may be 
due to an increase in type I collagen production following removal of TGF-β3, and possibly 
the formation of a collagen network less able to retain sGAG within the construct. Intense 
collagen type II staining was seen throughout the centre of both FS+ and DDC+ constructs 
continuously supplemented with TGF-β3. However when TGF-β3 supplementation ceased at 
day 21, a slight reduction in type II staining was evident by day 42; with significant type I 
staining observed, particularly in the annular region. Future studies will investigate whether 
this in indicative of a failure to achieve a stable chondrogenic phenotype following 21 days of 
culture in the presence of TGF-β3. 
sGAG release into the media was lower in the continuous dynamic compression 
(CDC) groups compared to FS controls. This demonstrates that the inhibition of 
chondrogenesis observed due to CDC from day 0 is not simply due to greater sGAG release 
into the media due to loading. Similarly the application of delayed dynamic compression did 
not lead to increases in sGAG release to the media, indicating that mechanical loading does 
not negatively influence sGAG retention in these immature chondrogenically primed 
constructs. 
The application of 1 hour of daily dynamic compression to MSC-laden constructs 
following three weeks of TGF-β3 induced differentiation did not enhance overall levels of 
cartilage matrix accumulation within the constructs. While a trend towards higher levels of 
sGAG/DNA was observed in constructs subjected to delayed dynamic compression, these 
differences were not significant. We were therefore unable to corroborate the initial 
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hypothesis of this study. A more complex picture emerges from the spatial analysis of sGAG 
accumulation within constructs subjected to delayed dynamic compression. In the construct 
core, dynamic compression was seen to have a small positive effect on sGAG accumulation 
following the withdrawal of TGF-β3. No statistical differences were observed between 
construct annuli. These differences may be due in part to spatial variations in the mechanical 
signals developed in cell seeded agarose hydrogels in response to dynamic unconfined 
compression24,44. Even in a homogenous tissue or hydrogel, MSCs in the annulus of the 
construct will experience higher levels of fluid flow in response to dynamic unconfined 
compression44. Furthermore, as greater tissue maturation is observed in the construct core 
compared to the annulus, this could potentially alter cell-level deformation and lead to 
increased fluid pressurisation within the construct core due to dynamic compression. Such 
hydrostatic fluid pressure is known to promote chondrogenesis of MSCs3,48,49,65. However, 
uncoupling the exact role of mechanical signals in regulating MSC chondrogenesis in this 
model system is further complicated by spatial gradients in oxygen, nutrients and growth 
factors that will develop within the engineered construct.  
When TGF-β3 was continuously maintained in the culture media, no significant 
differences in spatial sGAG accumulation were observed in DDC constructs compared to FS 
controls. The finding that MSC response to loading depends on TGF-β3 supplementation 
agrees with the observation of Li et al., who demonstrated greater differences between loaded 
and FS constructs at 0 or 1 ng/mL TGF-β1 concentrations41. They suggest that surface motion 
superimposed on 10% dynamic compression promotes chondrogenesis of MSCs seeded onto 
fibrin-polyurethane scaffolds through the TGF-β pathway by up-regulating TGF-β gene 
expression and protein synthesis. This may explain why delayed dynamic compression with 
the continued supplementation of TGF-β3 did not enhance sGAG accumulation in construct 
cores in the present study; as there may have been an overabundance of the growth factor 
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above what was required to stimulate maximal chondrogenesis, rendering any TGF-β 
production stimulated through dynamic compression ineffective. Alternatively, TGF-β may 
have been sequestered in the ECM during the first three weeks of FS culture, which may then 
be released during dynamic compression. This could possibly explain why an increase in 
sGAG is only observed in the construct core and not the annulus where potential TGF-β 
binding sites to sGAG are lower. 
 Large increases in the equilibrium modulus of any of the experimental groups were 
not observed despite increases in total sGAG and collagen within the constructs. This may be 
due to the inhomogeneous accumulation of matrix; with the majority of sGAG and collagen 
accumulation in the construct core. Inhomogeneous tissue development has been shown to 
influence the apparent mechanical properties of engineered cartilaginous tissue32. In addition, 
an important finding of this study is that the application of delayed dynamic compression did 
not lead to increases in the mechanical properties of the engineered tissue in either the 
continuous or transient TGF-β supplementation groups. This is in contrast to the results of 
studies subjecting chondrocytes seeded in agarose to delayed dynamic compression following 
pre-culture in a chemically defined medium supplemented with TGF-β42. There are a number 
of possible explanations for this finding. If cell mediated reorganisation of the engineered 
tissue in response to dynamic compression is responsible for the superior mechanical 
properties in chondrocyte seeded hydrogels, it may be that MSCs are unable to actively 
remodel their ECM in a similar manner in response to only 1 hour of daily dynamic 
compression. It may be that longer durations of loading are necessary for improvements in 
the mechanical properties of cartilaginous constructs engineered using MSCs. A recent study 
using bovine MSCs in a similar agarose model system demonstrated that 4 hours of delayed 
dynamic compression is necessary for improvements in tissue mechanical properties to be 
observed23. Another possible explanation is that other matrix molecules not investigated here 
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such as cartilage oligomeric matrix protein (COMP), which may play a key role in 
determining the functional properties of engineered cartilage tissues51, may be differentially 
expressed by MSCs and chondrocytes in response to loading. Alternatively, it may simply be 
that the beneficial effects of dynamic compression on the mechanical properties of tissue 
engineered cartilage will only become apparent once a certain minimum threshold of ECM is 
accumulated. Given that the total biochemical content of the cartilaginous tissues generated 
in this study are significantly lower than that observed with primary chondrocytes cultured 
under similar conditions12,42, future studies will investigate if altered culture conditions and 
MSC sources will lead to greater ECM accumulation prior to the application of dynamic 
compression. 
To conclude, in the presence of TGF-β3, the application of 10% dynamic compression 
for 1 hour per day from day 0 to day 42 inhibited chondrogenesis. In contrast, the application 
of 1 hour of daily dynamic compression from day 21 to day 42 following TGF-β3 induced 
differentiation did not inhibit chondrogenesis of MSCs; however neither did it lead to any 
increases in the functional properties of the tissue. In the context of cartilage tissue 
engineering, this study also demonstrated superior chondrogenesis in MSC-laden constructs 
maintained in TGF-β3 for the duration of the 42 day culture period; suggesting that continued 
supplementation with TGF-β3 at supra-physiological levels is a more potent chondrogenic 
stimulus than the dynamic compression regime utilised in this study. It has yet to be 
established if this is true for other types of mechanical loading regimes. Finally, this study 
could also be viewed as an in vitro model of how MSC-laden constructs might respond to a 
load bearing environment. In this case, allowing for a period of TGF-β induced 
differentiation produced a tissue that responded more positively to a load bearing 
environment. 
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Tables 
Table 1. Construct physical parameters of wet weight (mg), diameter (mm), thickness (mm), 
volume (µL), and density (kg/m3). ap < 0.05 vs. day 0; bp < 0.05 vs. day 21; cp < 0.05 vs. 
corresponding CDC group. 
 Day 0  Day 21  Day 42 
      Transient TGF-β3  Continuous TGF-β3 
   FS+ CDC+  FS- DDC- CDC-  FS+ DDC+ CDC+ 
Wet weight [mg] 42.8 
±4.9 
 
60.3 
±1.5a,c 
51.4 
±2.9a 
 
60.2 
±2.0a,c 
59.9 
±1.8a,c 
52.5 
±2.0a 
 
62.0 
±1.4a,c 
60.9 
±1.4a,c 
52.4 
±4.2a 
Diameter [mm] 5.024 
±0.043 
 
5.046 
±0.038 
5.001 
±0.030 
 
5.029 
±0.048 
5.118 
±0.070 
5.063 
±0.052 
 
5.195 
±0.093a,c 
5.103 
±0.063 
5.030 
±0.049 
Thickness [mm] 2.395 
±0.124 
 
3.063 
±0.073a,c 
2.792 
±0.028c 
 
2.979 
±0.132a,c 
2.990 
±0.055a,c 
2.664 
±0.090a 
 
3.112 
±0.043a,c 
3.027 
±0.097a,c 
2.746 
±0.045a 
Volume [µL] 47.29 
±1.91 
 
61.32 
±2.05a,c 
54.87 
±1.20a 
 
59.14 
±3.22a,c 
61.05 
±2.43a,c 
53.73 
±2.89a 
 
65.44 
±2.23a,c 
62.69 
±2.63a,c 
55.16 
±1.03a 
Density [kg/m3] 867.8 
±55.2 
 
983.1 
±22.1a 
936.3 
±53.0 
 
1023.8 
±21.9a 
996.5 
±38.2a 
980.7 
±29.3a 
 
956.6 
±47.5 
975.4 
±24.4a 
986.1 
±36.8a 
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Figure legends 
Figure 1. Schematic of experimental design. -TGF-β3: without TGF-β3 supplementation.  
+TGF-β3: with TGF-β3 supplementation. FS: free-swelling unloaded samples. DDC: delayed 
dynamic compression (maintained in free-swelling conditions for 21 days prior to dynamic 
compressive loading). CDC: continuous dynamic compression. -: transient TGF-β3 
supplementation. +: continuous TGF-β3 supplementation. n = 5 or 6 constructs per group per 
time point. 
 
Figure 2. Bioreactor setup; A: Petri dish with 1.5mm thick PTFE spacer holding up to 16 
constructs in position for loading. B: Constructs surrounded by medium in bioreactor for 
loading. C: Bioreactor during dynamic compression. 
 
Figure 3. Histological and immunohistochemical analysis for FS+ and CDC+ at day 21 with 
alcian blue staining for sulphated proteoglycan (top), picro-sirius red for collagen (second 
from top), collagen type I immunochemistry (third from top) and collagen type II 
immunohistochemistry (bottom). Representative images taken at the centre of each construct 
section. Scale bar: 100μm. 
 
Figure 4. Histological analysis of constructs at day 42 with alcian blue staining for sulphated 
proteoglycan (top) and picro-sirius red for collagen (bottom). FS: free-swelling. DDC: 
delayed dynamic compression, initiated on day 21. CDC: continuous dynamic compression, 
initiated on day 0. Representative images taken of approx. 1/4 of each construct section. Scale 
bar: 500μm. 
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Figure 5. Immunohistochemical analysis of constructs at day 42 with collagen type I 
immunohistochemistry (top) and collagen type II immunohistochemistry (bottom). FS: free-
swelling. DDC: delayed dynamic compression, initiated on day 21. CDC: continuous 
dynamic compression, initiated on day 0. Representative images taken of approx. 1/4 of each 
construct section. Scale bar: 500μm. 
 
Figure 6. Total biochemical composition of constructs for transient TGF-β3 (left) and 
continuous TGF-β3 (right). A: DNA content (ng/mg w/w); B: sGAG content (%w/w); C: 
sGAG/DNA (ng/ng); D: Collagen content (%w/w); E: Collagen/DNA (ng/ng). 
 
Figure 7: Biochemical composition of annulus and core at day 42 for constructs with transient 
TGF-β3 (left) and continuous TGF-β3 (right). A: DNA content (ng/mg w/w); B: sGAG 
content (%w/w); C: sGAG/DNA (ng/ng); D: Collagen content (%w/w); E: Collagen/DNA 
(ng/ng). 
 
Figure 8: A: sGAG secreted per construct to medium over the experimental time period (µg). 
a: p<0.05 vs. Day 0 – Day 21; b: p<0.05 vs. continuous TGF-β3; c: p<0.05 vs. CDC (same 
TGF-β3 condition); d: p<0.05 vs. DDC (same TGF-β3 condition). B: sGAG retained per 
construct (µg). ap < 0.05 vs. day 0; bp < 0.05 vs. day 21; cp < 0.05 vs. CDC; dp < 0.05 vs. 
continuous TGF-β3. Medium data cannot be matched to individual construct data as media is 
pooled during bioreactor culture. Data presented in this figure is pooled from multiple 
experimental runs. 
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Figure 9: Construct mechanical properties. A: Compressive equilibrium modulus and B: 1Hz 
dynamic modulus for transient TGF-β3 (left) and continuous TGF-β3 (right). a: p<0.05 vs. 
Day 0; b: p<0.05 vs. Day 21; c: p<0.05 vs. CDC (same TGF-β3 condition). 
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